Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 44
- Uncategorized
South Carolina Senator Reintroduces Medical Cannabis Reform Bill
South Carolina’s long-time cannabis advocate Senator, Tom Davis, has launched a fresh effort to legalize medical cannabis in the state.
- Press releases
Prime Minister Kretschmer of Saxony Visits Cannabis Group Grünhorn: “The Market for Medical Cannabis Has Great Potential”
Today’s visit by Prime Minister Michael Kretschmer, part of the CDU, a party known for its critical stance on cannabis, to Grünhorn in Leipzig marks a significant milestone in the political recognition of cannabis as a plant-based medicine.
- Uncategorized
What’s Next For Cannabis Rescheduling After Shock Delay?
The rescheduling of cannabis in the US, one of the most consequential cannabis reform efforts of the last century, is on increasingly uncertain ground amid a shock postponement and the introduction of a new enigmatic administration.
- Data & Analysis
Hundreds of UK Families Forced to Turn to Illicit Cannabis Market Due to Lack of NHS Access
This story was first reported on Cannabis Health News. Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report.
- Uncategorized
Florida Prepares for 2nd Vote on Adult Use Cannabis Legalization
Florida is poised to have another shot at legalizing adult-use cannabis, reigniting hopes that the US’s third most populous state could yet become the trigger event for the cannabis industry many had anticipated last year.
- CBD Market
UK CBD Business Sues Government for £3.4m Over ‘Unlawful’ Seizure of Hemp
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp.
- Companies
Cannabis Industry Giants Merge to Form Unified Advocacy Group in Washington
Two of the US’ biggest cannabis industry groups have joined forces, aiming to amplify the collective voice of nearly half a million employees as a new government administration is sworn in.
- Opinion
Canexis Pharma: Setting the Standard for Purity in Medical Cannabis
Ahead of the release of Prohibition Partners upcoming Global Cannabis Report: 5th Edition, we sat down with Sebastian Zeller, Managing Director of Canexis Pharma AG, a Swiss-based leader in medical cannabis production.
- Markets & Stocks
High Tide Breaks into German Market, Cantourage Exceeds Projections in 2024, & More from SEED
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
- Hemp Industry
DoorDash Begins Delivering CBD and Intoxicating Hemp Products
US store-to-door delivery giant DoorDash announced last week that it will begin offering CBD and intoxicating hemp substances through its service in response to growing demand.
- Medical
First Products Registered in Ukraine by Curaleaf Ahead of Medical Cannabis Rollout
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Amid Escalation of Tensions Between DEA and Other Witnesses
The highly anticipated hearings on cannabis rescheduling, set to begin next week, have now been cancelled in a major escalation of tensions between the Drug Enforcement Administration (DEA) and other witnesses.












